Company
United StatesPublic company, NYSE: LLYEli Lilly and Company (NYSE: LLY), Concord, NC – FDA Inspections
Inspection records and compliance data for Eli Lilly and Company in Concord, North Carolina. 2 FDA inspections on record, 2 Form 483s, last inspected February 11, 2026. Publicly traded as NYSE: LLY.
Company Profile
This profile covers Eli Lilly and Company based in Concord, North Carolina, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected November 26, 2024. Last inspected February 11, 2026.
Most cited issue areas
- Equipment Design, Size and Location1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 11, 2026 | Not classified | Human Drugs | 1309066 |
| November 26, 2024 | VAI | Human Drugs, Medical Devices & Rad Health · Compliance: Medical Devices | 1255082 |
FDA documents
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
DPT Laboratories Ltd
Vero Biotech Inc
Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)
Gland Pharma Limited, Units I+II Pashamylaram Site
Alliance Medical Products, Inc. DBA Siegfried Company
Professional Disposables International, Inc.
Hospira, Inc., A Pfizer Company
Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company
Cetylite Industries, Inc.
Pfizer Manufacturing Belgium NV
Company Information
Name
Eli Lilly and Company
Stock ticker
LLY
Exchange
NYSE
Share price
$1,430.13
Market cap
$1.3T
Price as of
November 13, 2026
FEI Number
3027403675
Address
1420 Concord Pkwy S, Concord, North Carolina 28027, United States
Country
United States
ID: 3ee60880-ca28-4c3e-a630-512617af2daa